Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q412888> ?p ?o }
Showing triples 1 to 50 of
50
with 100 triples per page.
- Q412888 subject Q7145095.
- Q412888 subject Q7483108.
- Q412888 subject Q7930599.
- Q412888 subject Q9688903.
- Q412888 abstract "Drotrecogin alfa (activated) (Xigris, marketed by Eli Lilly and Company) is a recombinant form of human activated protein C that has anti-thrombotic, anti-inflammatory, and profibrinolytic properties. Drotrecogin alpha (activated) belongs to the class of serine proteases. Drotrecogin alfa has not been found to improve outcomes in people with severe sepsis. The manufacturer's aggressive strategies in marketing its use in severe sepsis have been criticized. On October 25, 2011, Eli Lilly & Co. withdrew Xigris from the market after a major study showed no efficacy for the treatment of sepsis.".
- Q412888 atcPrefix "B01".
- Q412888 atcSuffix "AD10".
- Q412888 bioavailability "100.0".
- Q412888 casNumber "60202-16-6".
- Q412888 drugbank "DB00055".
- Q412888 iupacName "Activated human protein C".
- Q412888 wikiPageExternalLink xigris_USPI_17Dec04.pdf.
- Q412888 wikiPageExternalLink www.xigris.com.
- Q412888 wikiPageWikiLink Q1105202.
- Q412888 wikiPageWikiLink Q14864945.
- Q412888 wikiPageWikiLink Q14865480.
- Q412888 wikiPageWikiLink Q18216.
- Q412888 wikiPageWikiLink Q183134.
- Q412888 wikiPageWikiLink Q204711.
- Q412888 wikiPageWikiLink Q261327.
- Q412888 wikiPageWikiLink Q285697.
- Q412888 wikiPageWikiLink Q344843.
- Q412888 wikiPageWikiLink Q407431.
- Q412888 wikiPageWikiLink Q410237.
- Q412888 wikiPageWikiLink Q415915.
- Q412888 wikiPageWikiLink Q420032.
- Q412888 wikiPageWikiLink Q42395.
- Q412888 wikiPageWikiLink Q424381.
- Q412888 wikiPageWikiLink Q431289.
- Q412888 wikiPageWikiLink Q581996.
- Q412888 wikiPageWikiLink Q582728.
- Q412888 wikiPageWikiLink Q632240.
- Q412888 wikiPageWikiLink Q7145095.
- Q412888 wikiPageWikiLink Q7483108.
- Q412888 wikiPageWikiLink Q7930599.
- Q412888 wikiPageWikiLink Q9688903.
- Q412888 atcPrefix "B01".
- Q412888 atcSuffix "AD10".
- Q412888 bioavailability "100.0".
- Q412888 casNumber "60202".
- Q412888 drugbank "DB00055".
- Q412888 iupacName "Activated human protein C".
- Q412888 type ChemicalSubstance.
- Q412888 type Drug.
- Q412888 type ChemicalObject.
- Q412888 type Thing.
- Q412888 type Q8386.
- Q412888 comment "Drotrecogin alfa (activated) (Xigris, marketed by Eli Lilly and Company) is a recombinant form of human activated protein C that has anti-thrombotic, anti-inflammatory, and profibrinolytic properties. Drotrecogin alpha (activated) belongs to the class of serine proteases. Drotrecogin alfa has not been found to improve outcomes in people with severe sepsis. The manufacturer's aggressive strategies in marketing its use in severe sepsis have been criticized. On October 25, 2011, Eli Lilly & Co.".
- Q412888 label "Drotrecogin alfa".
- Q412888 homepage www.xigris.com.